TY  - BOOK
AU  - Loh, Joshua P
AU  - Satler, Lowell F
TI  - Management of a large atrial septal occluder embolized to the left ventricular outflow tract without the use of cardiac surgery
SN  - 1522-1946
KW  - *Cardiac Catheterization/mt [Methods]
KW  - *Device Removal/mt [Methods]
KW  - *Heart Septal Defects, Atrial/su [Surgery]
KW  - *Septal Occluder Device
KW  - Adult
KW  - Echocardiography, Transesophageal
KW  - Equipment Failure
KW  - Female
KW  - Follow-Up Studies
KW  - Heart Septal Defects, Atrial/di [Diagnosis]
KW  - Humans
KW  - MedStar Heart & Vascular Institute
N1  - Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006
N2  - Transcatheter closure of secundum-type atrial septal defects (ASDs) using the AMPLATZERTM Septal Occluder (ASO) has been in use for more than a decade since its US Food and Drug Administration approval in 2001. Device embolization remains an uncommon complication, which can sometimes occur after the initial deployment. Previous reports of ASO devices embolized to the left ventricle have primarily been managed by open-heart surgical retrieval. We present a case of an ASO device embolized to the left ventricular outflow tract (LVOT) 18 hr after initial implantation, which was successfully retrieved percutaneously, followed by successful closure of the ASD using a larger device.Copyright © 2014 Wiley Periodicals, Inc
UR  - http://dx.doi.org/10.1002/ccd.25361
ER  -